@truequest2
The White House is launching a new payment platform.
It focuses on popular GLP-1 medications.
The goal is to let patients pay cash directly.
This aims to pressure major drug companies.
It also seeks to bypass middlemen.
These intermediaries often keep U.S. drug prices high.
0 reply
0 recast
0 reaction